2025. THE EFFECTIVENESS, IMMUNOGENICITY, AND SAFETY OF THE Escherichia coli BASED BIVALENT HUMAN PAPILLOMAVIRUS (TYPES 16 AND 18) VACCINE PREVENTING CERVICAL CANCER: A Systematic Review. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia. 11, 3 (Apr. 2025), 21–37. DOI:https://doi.org/10.53366/jimki.v11i3.795.